Journal
NATURE COMMUNICATIONS
Volume 11, Issue 1, Pages -Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-020-17380-5
Keywords
-
Categories
Funding
- National Cancer Institute [R01CA218659, R01EB026207]
- National Institute of Biomedical Imaging and Bioengineering [R01CA218659, R01EB026207]
- Center for Translational Imaging and Mouse Histology and Phenotyping Laboratory at Northwestern University
Ask authors/readers for more resources
We report a strategy to boost Fenton reaction triggered by an exogenous circularly polarized magnetic field (MF) to enhance ferroptosis-like cell-death mediated immune response, as well as endow a responsive MRI capability by using a hybrid core-shell vesicles (HCSVs). HCSVs are prepared by loading ascorbic acid (AA) in the core and poly(lactic-co-glycolic acid) shell incorporating iron oxide nanocubes (IONCs). MF triggers the release of AA, resulting in the increase of ferrous ions through the redox reaction between AA and IONCs. A significant tumor suppression is achieved by Fenton reaction-mediated ferroptosis-like cell-death. The oxidative stress induced by the Fenton reaction leads to the exposure of calreticulin on tumor cells, which leads to dendritic cells maturation and the infiltration of cytotoxic T lymphocytes in tumor. Furthermore, the depletion of ferric ions during treatment enables monitoring of the Fe reaction in MRI-R2* signal change. This strategy provides a perspective on ferroptosis-based immunotherapy. The immune system can eradicate tumours, and several chemotherapy strategies have been reported to augment the immune system. Here, the authors report an exogenous magnetic field triggered strategy to boost Ferroptosis-like death and endow responsive MRI by using a biosafe hybrid core-shell vesicle for cancer therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available